Moneycontrol

Moneycontrol PRO

you are here: HomeNewsBusinessStocksDiwan`s view on Aurobindo Pharma

SHOW NAMES

Trending Topics

business

Diwan`s view on Aurobindo Pharma

Prakash Diwan, Head-Institutional Business, Networth Stock Broking feels that, Aurobindo tends to be in the zone of shorts and it finds it very difficult to cross that Rs200-202 mark.

first published: Jun 8, 2011 03:44 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347